Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Peptic Ulcer

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    August 2019
  1. CHEN MJ, Fang YJ, Wu MS, Chen CC, et al
    Application of Helicobacter pylori stool antigen test to survey the updated prevalence of H. pylori infection in Taiwan.
    J Gastroenterol Hepatol. 2019 Aug 13. doi: 10.1111/jgh.14828.
    PubMed     Text format     Abstract available


  2. TANAKA S, Toyonaga T, Kawara F, Watanabe D, et al
    The novel per-oral endoscopic myotomy method preserving oblique muscle using two penetrating vessels as anatomic landmarks reduces postoperative gastroesophageal reflux.
    J Gastroenterol Hepatol. 2019 Aug 1. doi: 10.1111/jgh.14814.
    PubMed     Text format     Abstract available


    July 2019
  3. SARKESHIKIAN SS, Ghadir MR, Alemi F, Jalali SM, et al
    Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial.
    J Gastroenterol Hepatol. 2019 Jul 29. doi: 10.1111/jgh.14810.
    PubMed     Text format     Abstract available


  4. HUSSAIN S, Singh A, Zameer S, Jamali MC, et al
    No association between proton pump inhibitors use and risk of dementia: Evidence from a meta-analysis.
    J Gastroenterol Hepatol. 2019 Jul 23. doi: 10.1111/jgh.14789.
    PubMed     Text format     Abstract available


  5. SIVANES S, Chang J
    Gastrointestinal: A rare cause of upper gastrointestinal bleeding: Epiphrenic esophageal diverticula.
    J Gastroenterol Hepatol. 2019 Jul 4. doi: 10.1111/jgh.14755.
    PubMed     Text format    


  6. DEGUCHI H, Yamazaki H, Yamamoto Y, Fukuhara S, et al
    Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring.
    J Gastroenterol Hepatol. 2019 Jul 1. doi: 10.1111/jgh.14774.
    PubMed     Text format     Abstract available


    June 2019
  7. JIANG K, Jiang X, Wen Y, Liao L, et al
    Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis.
    J Gastroenterol Hepatol. 2019 Jun 17. doi: 10.1111/jgh.14759.
    PubMed     Text format     Abstract available


    May 2019
  8. PARK SK, Nam JH, Lee H, Chung H, et al
    Beyond uncertainty: negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    J Gastroenterol Hepatol. 2019 May 30. doi: 10.1111/jgh.14745.
    PubMed     Text format     Abstract available


  9. HSU PI, Pan CY, Kao JY, Tsay FW, et al
    Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
    J Gastroenterol Hepatol. 2019 May 22. doi: 10.1111/jgh.14736.
    PubMed     Text format     Abstract available


  10. ADACHI K, Notsu T, Mishiro T, Kinoshita Y, et al
    Long-term effect of Helicobacter pylori eradication on prevalence of reflux esophagitis.
    J Gastroenterol Hepatol. 2019 May 21. doi: 10.1111/jgh.14730.
    PubMed     Text format     Abstract available


  11. YORITA N, Ito M, Boda T, Kotachi T, et al
    Potential of Helicobacter pylori-uninfected signet ring cell carcinoma to invade the submucosal layer.
    J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14706.
    PubMed     Text format     Abstract available


    April 2019
  12. WONG SH, Sung JJ
    When repeated Helicobacter pylori therapies fail, what should we do?
    J Gastroenterol Hepatol. 2019;34:627-628.
    PubMed     Text format    


    March 2019
  13. PITTAYANON R, Piyachaturawat P, Rerknimitr R, Prueksapanich P, et al
    Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.
    J Gastroenterol Hepatol. 2019 Mar 28. doi: 10.1111/jgh.14671.
    PubMed     Text format     Abstract available


  14. MIYAZAKI H, Igarashi A, Takeuchi T, Teng L, et al
    Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: a systematic review.
    J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14664.
    PubMed     Text format     Abstract available


  15. FOUAD TR, Abdelsameea E, Abdel-Razek W, Attia A, et al
    Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post-therapeutic outcome and prognostic indicators.
    J Gastroenterol Hepatol. 2019 Mar 14. doi: 10.1111/jgh.14659.
    PubMed     Text format     Abstract available


  16. WONG MW, Bair MJ, Chang WC, Hsu CS, et al
    Clinical and psychological characteristics in GERD patients overlapping with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14651.
    PubMed     Text format     Abstract available


    February 2019
  17. CHOI YK, Ahn JY, Won SH, Jung K, et al
    Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.
    J Gastroenterol Hepatol. 2019 Feb 27. doi: 10.1111/jgh.14639.
    PubMed     Text format     Abstract available


  18. LIOU TC, Liao PH, Lin YC, Chu CH, et al
    Intraluminal therapy for Helicobacter pylori infection.
    J Gastroenterol Hepatol. 2019 Feb 8. doi: 10.1111/jgh.14627.
    PubMed     Text format     Abstract available


  19. LEE JW, Kim N, Nam RH, Lee SM, et al
    Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2019 Feb 6. doi: 10.1111/jgh.14625.
    PubMed     Text format     Abstract available


    January 2019
  20. CHAN JSH, Chao ACW, Cheung VCH, Wong SSK, et al
    Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014.
    J Gastroenterol Hepatol. 2019;34:124-131.
    PubMed     Text format     Abstract available


    December 2018
  21. WANG KY, Chen YW, Wang TN, Hsu WH, et al
    Predictor of Slower Gastric Emptying in Gastroesophageal Reflux Disease-Survey of An Asian-Pacific Cohort.
    J Gastroenterol Hepatol. 2018 Dec 14. doi: 10.1111/jgh.14572.
    PubMed     Text format     Abstract available



  22. Retraction: Usefulness of Helicobacter pylori eradication for precancerous lesions of the gastric remnant.
    J Gastroenterol Hepatol. 2018;33:2055.
    PubMed     Text format    


    November 2018
  23. ZHENG W, Jiang L, Jia X, Long G, et al
    Analysis of risk factors and development of scoring system to predict severity of upper gastrointestinal bleeding in children.
    J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14548.
    PubMed     Text format     Abstract available


  24. SARRI GL, Grigg SE, Yeomans ND
    Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis.
    J Gastroenterol Hepatol. 2018 Nov 8. doi: 10.1111/jgh.14539.
    PubMed     Text format     Abstract available


    August 2018
  25. YEO YH, Hsu CC, Lee CC, Ho HJ, et al
    Systematic review with network meta-analysis: Effectiveness of therapies for second-line Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2018 Aug 31. doi: 10.1111/jgh.14462.
    PubMed     Text format     Abstract available


  26. SUE S, Shibata W, Sasaki T, Kaneko H, et al
    Randomized Trial of Vonoprazan- Versus PPI-Based Third-Line Triple Therapy With Sitafloxacin for Helicobacter pylori.
    J Gastroenterol Hepatol. 2018 Aug 27. doi: 10.1111/jgh.14456.
    PubMed     Text format     Abstract available


  27. WU SC, Chen WT, Muo CH, Hsu CY, et al
    A comparative study of subsequent liver cirrhosis risk in non- helicobacter pylori infected peptic ulcer patients with and without vagotomy: an Asian population cohort study.
    J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14440.
    PubMed     Text format     Abstract available


  28. MOURAD FH, Leong RW
    Role of hemostatic powders in the management of lower gastrointestinal bleeding: A review.
    J Gastroenterol Hepatol. 2018;33:1445-1453.
    PubMed     Text format     Abstract available


    July 2018
  29. CHO JH, Jeon SR, Kim HG, Jin SY, et al
    Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.
    J Gastroenterol Hepatol. 2018 Jul 16. doi: 10.1111/jgh.14383.
    PubMed     Text format     Abstract available


    June 2018
  30. ADACHI K, Notsu T, Mishiro T, Yoshikawa H, et al
    Influence of Helicobacter pylori infection on periodontitis.
    J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14358.
    PubMed     Text format     Abstract available


    May 2018
  31. AUESOMWANG C, Maneerattanaporn M, Chey WD, Kiratisin P, et al
    Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2018 May 27. doi: 10.1111/jgh.14292.
    PubMed     Text format     Abstract available


  32. MIN YW, Kim Y, Gwak GY, Gu S, et al
    Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
    J Gastroenterol Hepatol. 2018;33:1053-1058.
    PubMed     Text format     Abstract available


    March 2018
  33. LU B, Zhang L, Wang J, Wang B, et al
    Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: a survey of Chinese patients (the ENLIGHT Study).
    J Gastroenterol Hepatol. 2018 Mar 25. doi: 10.1111/jgh.14143.
    PubMed     Text format     Abstract available


  34. CHOWDHRY M, Shah K, Kemper S, Zekan D, et al
    Proton pump inhibitors are not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    J Gastroenterol Hepatol. 2018 Mar 7. doi: 10.1111/jgh.14141.
    PubMed     Text format     Abstract available


  35. GOH KL
    Lessons Learnt from the Epidemiology of Helicobacter Pylori Infection in Malaysia Jghf Marshall and Warren Lecture 2017.
    J Gastroenterol Hepatol. 2018 Mar 2. doi: 10.1111/jgh.14131.
    PubMed     Text format     Abstract available


  36. OKANO A, Ohana M
    Gastrointestinal: Improvement of refractory oral ulcer of Behcet's disease after eradication of Helicobacter pylori.
    J Gastroenterol Hepatol. 2018;33:560.
    PubMed     Text format    


    February 2018
  37. PARK JC, Kim YJ, Kim EH, Lee J, et al
    Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding: using propensity score matching.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14118.
    PubMed     Text format     Abstract available


    January 2018
  38. ROBERTS-THOMSON IC
    THE RISE AND FALL OF PEPTIC ULCERATION: A DISEASE OF CIVILIZATION?
    J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1111/jgh.14090.
    PubMed     Text format     Abstract available


    December 2017
  39. TAKAHASHI Y, Takeuchi T, Kojima Y, Nagami Y, et al
    Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2017 Dec 19. doi: 10.1111/jgh.14073.
    PubMed     Text format     Abstract available


  40. MA J, Hiratsuka T, Etoh T, Akada J, et al
    Anti-proliferation effect of blue light-emitting diodes against antibiotic-resistant Helicobacter pylori.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14066.
    PubMed     Text format     Abstract available


    November 2017
  41. XU MY, Ma JH, Yuan BS, Yin J, et al
    Association between helicobacter pylori infection and gallbladder diseases: a retrospective study.
    J Gastroenterol Hepatol. 2017 Nov 27. doi: 10.1111/jgh.14054.
    PubMed     Text format     Abstract available


  42. MISHIRO T, Oka K, Kuroki Y, Takahashi M, et al
    Proton pump inhibitor alters oral microbiome in gastrointestinal tract of healthy volunteers.
    J Gastroenterol Hepatol. 2017 Nov 4. doi: 10.1111/jgh.14040.
    PubMed     Text format     Abstract available


  43. KIM GU, Seo M, Song EM, Hwang SW, et al
    Association between the ulcer status and the risk of delayed bleeding after the endoscopic mucosal resection of colon.
    J Gastroenterol Hepatol. 2017;32:1846-1851.
    PubMed     Text format     Abstract available


    September 2017
  44. MANABE N, Haruma K, Kusunoki H, Kamada T, et al
    Differences in Salivary Secretory Function between Patients with Erosive Esophagitis and Those with Nonerosive Reflux Disease.
    J Gastroenterol Hepatol. 2017 Sep 27. doi: 10.1111/jgh.14002.
    PubMed     Text format     Abstract available


    July 2017
  45. MIN S, Kim N, Kwon YH, Hee R, et al
    RdxA, frxA and efflux pump in metronidazole-resistant Helicobacter pylori: their relation to clinical outcomes.
    J Gastroenterol Hepatol. 2017 Jul 27. doi: 10.1111/jgh.13906.
    PubMed     Text format     Abstract available


  46. AGARWAL J, Hasan A, Mehrotra M
    Hepatobiliary and Pancreatic: Hepatogastric fistula.
    J Gastroenterol Hepatol. 2017;32:1284.
    PubMed     Text format    


    May 2017
  47. YANG EH, Cheng HC, Wu CT, Chen WY, et al
    Peptic ulcer bleeding patients with Rockall Scores >/= 6 are at risk of long-term ulcer rebleeding: a 3.5-year prospective longitudinal study.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13822.
    PubMed     Text format     Abstract available


  48. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    PubMed     Text format     Abstract available


    January 2017
  49. BATCHELOR R, Gilmartin JF, Kemp W, Hopper I, et al
    Dementia, cognitive impairment and proton pump inhibitor therapy - a systematic review.
    J Gastroenterol Hepatol. 2017 Jan 27. doi: 10.1111/jgh.13750.
    PubMed     Text format     Abstract available


  50. EUSEBI LH, Rabitti S, Artesiani ML, Gelli D, et al
    PROTON PUMP INHIBITORS: RISKS OF LONG-TERM USE.
    J Gastroenterol Hepatol. 2017 Jan 16. doi: 10.1111/jgh.13737.
    PubMed     Text format     Abstract available


  51. LEE YC, Lin JT
    Screening and Treating Helicobacter pylori Infection for Gastric Cancer Prevention on the Population Level.
    J Gastroenterol Hepatol. 2017 Jan 14. doi: 10.1111/jgh.13726.
    PubMed     Text format     Abstract available


  52. GONG EJ, Choi KD, Jung HK, Youn YH, et al
    Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13716.
    PubMed     Text format     Abstract available


  53. KONO Y, Kawano S, Takaki A, Shimomura Y, et al
    Oxidative stress controlling agents are effective for small intestinal injuries induced by non-steroidal anti-inflammatory drugs.
    J Gastroenterol Hepatol. 2017;32:136-145.
    PubMed     Text format     Abstract available


    December 2016
  54. ZOU D, Goh KL
    An East Asian Perspective on the Interaction between Proton Pump Inhibitors and Clopidogrel.
    J Gastroenterol Hepatol. 2016 Dec 26. doi: 10.1111/jgh.13712.
    PubMed     Text format     Abstract available


    November 2016
  55. ON ZX, Grant J, Shi Z, Taylor AW, et al
    The association between gastroesophageal reflux disease (GERD) with sleep quality, depression and anxiety in a cohort study of Australian men.
    J Gastroenterol Hepatol. 2016 Nov 11. doi: 10.1111/jgh.13650.
    PubMed     Text format     Abstract available


    October 2016
  56. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
    Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
    PubMed     Text format     Abstract available


    September 2016
  57. JUNG SW, Kim SY, Choe JW, Hyun JJ, et al
    Standard and double dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection.
    J Gastroenterol Hepatol. 2016 Sep 16. doi: 10.1111/jgh.13597.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: